$Aditxt (ADTX.US)$$Evofem Biosciences (EVFM.US)$Press Release: Aditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024 Dow Jones· 2 mins ago
$Evofem Biosciences (EVFM.US)$Evofem Biosciences Addresses Impact Of GLP-1 Medications On Oral Contraceptive Absorption And Introduces Phexxi As A Non-Oral Solution Benzinga· 8 mins ago As the popularity of GLP-1 receptor agonists continues to surge in the treatment of obesity and type 2 diabetes, Evofem Biosciences, Inc. (OTCQB:EVFM) is raising awareness of the potential impact these medications may have on the effectiveness of oral contraceptives. With an increasing number of women turning ...
Impressive Surge: $Evofem Biosciences (EVFM.US)$stock experienced a significant surge, doubling its value today, catching attention in the micro-cap stocks category. Despite its niche focus on women's health products, EVFM's long-term chart has been unimpressive, trending towards zero. Market Capitalization and Acquisition Offer: The company currently trades at a market capitalization of only $1.4 million. Surprisingly, Evofem received an acquisition offer from$Aditxt (ADTX.US)$valued at...
3
Report
No comment yet
Sign in to post a comment
Trending Stocks
Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Evofem Biosciences Stock Forum
Dow Jones· 2 mins ago
Benzinga· 8 mins ago
As the popularity of GLP-1 receptor agonists continues to surge in the treatment of obesity and type 2 diabetes, Evofem Biosciences, Inc. (OTCQB:EVFM) is raising awareness of the potential impact these medications may have on the effectiveness of oral contraceptives. With an increasing number of women turning ...
Evofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of Matter
$Evofem Biosciences (EVFM.US)$ stock experienced a significant surge, doubling its value today, catching attention in the micro-cap stocks category. Despite its niche focus on women's health products, EVFM's long-term chart has been unimpressive, trending towards zero.
Market Capitalization and Acquisition Offer:
The company currently trades at a market capitalization of only $1.4 million. Surprisingly, Evofem received an acquisition offer from $Aditxt (ADTX.US)$ valued at...
No comment yet